Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry.
Saved in:
| Title: | Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry. |
|---|---|
| Authors: | Máspero JF; Fundación CIDEA, Paraguay 2035, 3° Cuerpo 2° Subsuelo, C1121ABE, Ciudad Autónoma de Buenos Aires, Argentina. jorge.maspero@fundacioncidea.org.ar., Arnaout RK; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., Vargas-Ramírez L; Instituto Neumológico del Oriente, Bucaramanga, Colombia., Mobayed H; Hamad Medical Corporation, Doha, Qatar., Mahboub B; Rashid Hospital, Dubai, UAE., Irani C; Hôtel-Dieu de France Hospital, Beirut-Saint Joseph University, Beirut, Lebanon., Bar-Shai A; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Tel Aviv University, Tel Aviv, Israel., Koh MS; Singapore General Hospital, Singapore, Singapore., Chao J; Sanofi, Morristown, NJ, USA., Zaghloul S; Sanofi, Dubai, UAE., Kwah JH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Dewhurst J; Sanofi, Reading, UK., Al-Ahmad MS; College of Medicine, Kuwait University, Kuwait City, Kuwait.; Al-Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait. |
| Source: | Advances in therapy [Adv Ther] 2026 Jun 10. Date of Electronic Publication: 2026 Jun 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42268495 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Máspero+JF%22">Máspero JF</searchLink>; Fundación CIDEA, Paraguay 2035, 3° Cuerpo 2° Subsuelo, C1121ABE, Ciudad Autónoma de Buenos Aires, Argentina. jorge.maspero@fundacioncidea.org.ar.<br /><searchLink fieldCode="AU" term="%22Arnaout+RK%22">Arnaout RK</searchLink>; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Vargas-Ramírez+L%22">Vargas-Ramírez L</searchLink>; Instituto Neumológico del Oriente, Bucaramanga, Colombia.<br /><searchLink fieldCode="AU" term="%22Mobayed+H%22">Mobayed H</searchLink>; Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Mahboub+B%22">Mahboub B</searchLink>; Rashid Hospital, Dubai, UAE.<br /><searchLink fieldCode="AU" term="%22Irani+C%22">Irani C</searchLink>; Hôtel-Dieu de France Hospital, Beirut-Saint Joseph University, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Bar-Shai+A%22">Bar-Shai A</searchLink>; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Koh+MS%22">Koh MS</searchLink>; Singapore General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chao+J%22">Chao J</searchLink>; Sanofi, Morristown, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zaghloul+S%22">Zaghloul S</searchLink>; Sanofi, Dubai, UAE.<br /><searchLink fieldCode="AU" term="%22Kwah+JH%22">Kwah JH</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dewhurst+J%22">Dewhurst J</searchLink>; Sanofi, Reading, UK.<br /><searchLink fieldCode="AU" term="%22Al-Ahmad+MS%22">Al-Ahmad MS</searchLink>; College of Medicine, Kuwait University, Kuwait City, Kuwait.; Al-Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2026 Jun 10. <i>Date of Electronic Publication: </i>2026 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42268495 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-026-03623-2 Languages: – Code: eng Text: English Titles: – TitleFull: Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Máspero JF – PersonEntity: Name: NameFull: Arnaout RK – PersonEntity: Name: NameFull: Vargas-Ramírez L – PersonEntity: Name: NameFull: Mobayed H – PersonEntity: Name: NameFull: Mahboub B – PersonEntity: Name: NameFull: Irani C – PersonEntity: Name: NameFull: Bar-Shai A – PersonEntity: Name: NameFull: Koh MS – PersonEntity: Name: NameFull: Chao J – PersonEntity: Name: NameFull: Zaghloul S – PersonEntity: Name: NameFull: Kwah JH – PersonEntity: Name: NameFull: Dewhurst J – PersonEntity: Name: NameFull: Al-Ahmad MS IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 06 Text: 2026 Jun 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1865-8652 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |